The U.S. Food and Drug Administration (FDA) has approved a wearable medical device used in combination with a standard chemotherapy...
FDA
The U.S. Food and Drug Administration (FDA) approved Poherdy (pertuzumab-dpzb) as the first interchangeable biosimilar to Perjeta (pertuzumab) for patients...
The FDA recently approved Teal Wand, the first at-home, vaginal, self-collection device for cervical cancer screening, according to a news...
The Food and Drug Administration this week told several drugmakers to add a boxed warning — the agency’s strongest safety...
